As a Pharmaceutical Intermediates Manufacturers, share with you.
Looking at the entire industry, there are currently six major characteristics in the production of pharmaceutical intermediates in my country:
Pharmaceutical Intermediates
Features
The first is that most of the production companies are private enterprises with flexible operation and small investment scale, basically between several million and one to 20 million yuan. The second is that the geographical distribution of production companies is relatively concentrated, mainly in Taizhou, Zhejiang and Jinjiang, Jiangsu. Altar is the center area; third, as the country pays more and more attention to environmental protection issues, the pressure of manufacturing enterprises to build environmental protection treatment facilities has increased; fourth, the product update speed is fast. Generally, after a product has been on the market for 3 to 5 years, its profit margin will drop significantly. This forces companies to continuously develop new products or continuously improve production processes in order to maintain high production profits. Fifth, because of the high production profits of pharmaceutical intermediates For chemical products, the production processes of the two are basically the same, so more and more small chemical companies have joined the ranks of producing pharmaceutical intermediates, resulting in increasingly fierce disorderly competition in the industry. Sixth, compared with APIs, production The profit margin of intermediates is low, and the production process of APIs and pharmaceutical intermediates is similar. Therefore, some companies have not only produced intermediates, but also used their own advantages to start the production of APIs.
The impact of the economic globalization process has the most far-reaching impact on China’s economy than its philosophy that each production enterprise does not need to be large but should concentrate its capital and energy on other supporting materials and conditions in the industries and fields that it is good at. It can be completed by social collaboration, through the formation of a product chain, so that both parties can achieve a win-win situation. Under the influence of this concept, the pharmaceutical industry transfers the processing of some primary products, such as solvent recovery, to cooperative companies. Hazardous products are transferred to chemical plants for production. For example, phenylacetic acid and chloroacetic acid used in the production of penicillin have been produced near Shijiazhuang since the 1970s and 1980s. There have been a large number of small township enterprises and individual enterprises supporting the production of phenylacetic acid and chloroacetic acid for North China Pharmaceutical.
Our company also has Pharmaceutical Intermediates on sale, welcome to contact us.
